- January 20, 2012
- MHLW APPROVES PARTIAL LABEL CHANGE FOR
EGG WHITE LYSOZYME PREPARATION NEUZYM®,
DESIGNATES DRUG FOR REEVALUATION - January 19, 2012
- Eisai and EIDIA Announce Launch of LIFE CHECK,
a Self-monitoring Blood Glucose Meter That is Easy for
Elderly Diabetes Patients to Use - January 18, 2012
- EISAI RECEIVES APPROVAL TO MARKET INSOMNIA TREATMENT
LUNESTA® IN JAPAN
- January 26, 2012
- Access to Medicines “Delivering More High-Quality Eisai Products to More Patients Around the World ”
- December 28, 2011
- Access to Medicines “Access to medicines from our hhc philosophy”
- November 15, 2011
- Commitment & Passion for hhc ”Striving to Realize Customer Joy - A Look Back Over the Past Two and a Half Years”
- January 11, 2012
- U.S. FDA Accepts Resubmission of Lorcaserin New Drug Application
- December 15, 2011
- EISAI'S INDIAN MANUFACTURING BASE RECEIVES APPROVAL FROM U.S. FDA TO MANUFAC ALZHEIMER'S DISEASE TREATMENT ARICEPT®
- December 5, 2011
- STATEMENT: FARLETUZUMAB AND THE FAR 122 STUDY
- November 17, 2011
- NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE): FINAL APPRAISAL DETERMINATION FOR HALAVEN® (ERIBULIN)
